Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Table of Contents

July 01, 2008; Volume 75,Issue 7

From the Editor

  • You have access
    A drug, a concept, and a clinical trial on trial
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine July 2008, 75 (7) 470;

    The ENHANCE trial, evaluating the addition of a second hypocholesterolemic drug (ezetimibe) to a statin using two surrogate end points in a relatively small number of patients, hit the national news when the two surrogates didn’t match up.

The Clinical Picture

  • You have access
    Generalized pruritus after a beach vacation
    Sergio Vañó-Galván, MD and Paula Moreno-Martin, MD
    Cleveland Clinic Journal of Medicine July 2008, 75 (7) 474-478;

    A 25-year-old man presents with a 2-month history of generalized itching that began 5 weeks after a trip to Brazil, during which he had sexual relations without protection. What is the most likely diagnosis?

Commentary

  • You have access
    Interpreting the Enhance Trial
    Michael H. Davidson, MD
    Cleveland Clinic Journal of Medicine July 2008, 75 (7) 479-491;

    The impact of the ENHANCE trial reveals more about the political climate than it does about the effects of ezetimibe on the progression of atherosclerosis.

Editorial

  • You have access
    Given the ENHANCE trial results, ezetimibe is still unproven
    Allen J. Taylor, MD
    Cleveland Clinic Journal of Medicine July 2008, 75 (7) 497-506;

    We should beware of explaining away results that do not match our expectations.

Review

  • You have access
    Bacterial conjunctivitis: A review for internists
    Ahmad B. Tarabishy, MD and Bennie H. Jeng, MD
    Cleveland Clinic Journal of Medicine July 2008, 75 (7) 507-512;

    It is critical to differentiate bacterial conjunctivitis from other types of conjunctivitis and more serious vision-threatening conditions so that patients can be appropriately treated and, if necessary, referred to an ophthalmologist.

  • You have access
    Perioperative beta-blockers in noncardiac surgery: Evolution of the evidence
    Brian Harte, MD and Amir K. Jaffer, MD
    Cleveland Clinic Journal of Medicine July 2008, 75 (7) 513-519;

    The pendulum of opinion is swinging away from routinely recommending beta-blockers to prevent cardiac events in surgical patients. We will probably be using them more selectively than in the past.

  • Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease
    You have access
    Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease
    Steve M. Blevins, MD, Ronald A. Greenfield, MD and Michael S. Bronze, MD
    Cleveland Clinic Journal of Medicine July 2008, 75 (7) 521-530;

    Blood smear analysis should be performed in patients with persistent or recurring fever, those who have traveled to the developing world, or those who have a history of tick exposure, especially if accompanied by hemolytic anemia, thrombocytopenia, or hepatosplenomegaly.

  • You have access
    From the Children’s Oncology Group
    Allen Liles, MD, Julie Blatt, MD, David Morris, MD, Richard Wardrop, MD, Anjali Sharma, MD, Aimee Sznewajs, MS, PNP and Robert Goldsby, MD
    Cleveland Clinic Journal of Medicine July 2008, 75 (7) 531-539;

    Children who undergo radiotherapy, chemotherapy, or surgery for cancer face a risk of complications later in life, including pulmonary fibrosis and pneumonitis. They need systematic, lifelong surveillance.

The Clinical Picture

  • You have access
    Dyspnea, arthralgias, and muscle weakness
    Rachel M. Taliercio, DO and Jeffrey Chapman, MD
    Cleveland Clinic Journal of Medicine July 2008, 75 (7) 540-542;

    A computed tomographic scan shows ground-glass opacities in the lower lobes of both lungs. What is the most likely cause of this patient’s symptoms and radiographic findings?

Departments

  • You have access
    VTE prevention in major orthopedic surgery (Supplement 3 to Volume 75, April 2008)
    Andrew Fishmann, MD
    Cleveland Clinic Journal of Medicine July 2008, 75 (7) 471;

    Venous thromboembolism prevention in major orthopedic surgery.

  • You have access
    VTE prevention in major orthopedic surgery (Supplement 3 to Volume 75, April 2008)
    Harold S. Boyd, MD
    Cleveland Clinic Journal of Medicine July 2008, 75 (7) 471-472;
  • You have access
    In reply: VTE prevention in major orthopedic surgery (Supplement 3 to Volume 75, April 2008)
    Steven B. Deitelzweig, MD, Alpesh N. Amin, MD, MBA, Daniel J. Brotman, MD, Sylvia C. McKean, MD, Alex C. Spyropoulos, MD and Amir K. Jaffer, MD
    Cleveland Clinic Journal of Medicine July 2008, 75 (7) 472-473;
Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 75 (7)
Cleveland Clinic Journal of Medicine
Vol. 75, Issue 7
1 Jul 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Sign up for alerts

Jump to

  • From the Editor
  • The Clinical Picture
  • Commentary
  • Editorial
  • Review
  • The Clinical Picture
  • Departments
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
The beat goes on: Highlights from the new American and European A-fib guidelines
What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
Tinea incognito
Prolonged venous filling time and dependent rubor in a patient with peripheral artery disease
Nociplastic pain: A practical guide to chronic pain management in the primary care setting
Sarcoidosis with diffuse purplish erythematous plaques on the hands
Cardiovascular disease in people living with HIV: Risk assessment and management
Heart to heart: Progress in cardiovascular disease prevention for people living with HIV
Don’t judge a book by its cover: Unusual presentations of pericardial disease
Hypoglycemia after bariatric surgery: Management updates
Risk-factor modification to prevent recurrent atrial fibrillation after catheter ablation
Common electrolyte imbalance, uncommon cause

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire